Back
New Concept Energy Vs. Vaxcyte Industry Stock Comparison
Sell
47
GBR
New Concept Energy
Last Price:
$0.93
Seasonality Move:
10.48%
Buy
54
PCVX
Vaxcyte
Last Price:
$36.98
Seasonality Move:
13.5%
Sell
47
New Concept Energy (GBR)
is a Sell
Is New Concept Energy a Buy, Sell or Hold?
-
The current New Concept Energy [GBR] share price is $0.93. The Score for GBR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
GBR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBR Stock Price Chart
What is New Concept Energy's stock price today?
-
The New Concept Energy share price today is $0.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBR is experiencing selling pressure, which indicates risk of future bearish movement.
PCVX Stock Price Chart
GBR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 55.27 | Buy |
Chaikin Money Flow: | -7921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.84 - 0.94) | Buy |
Bollinger Bands (100): | (0.78 - 1.14) | Sell |
PCVX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 57.27 | Buy |
Chaikin Money Flow: | 1400793 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.52 - 34.84) | Buy |
Bollinger Bands (100): | (32.86 - 82.04) | Sell |
GBR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.92 | Buy |
20-day SMA: | 0.91 | Buy |
50-day SMA: | 0.82 | Buy |
200-day SMA: | 1.08 | Sell |
8-day EMA: | 0.92 | Buy |
20-day EMA: | 0.9 | Buy |
50-day EMA: | 0.88 | Buy |
200-day EMA: | 1.04 | Sell |
PCVX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34 | Buy |
20-day SMA: | 32.89 | Buy |
50-day SMA: | 33.98 | Buy |
200-day SMA: | 78.17 | Sell |
8-day EMA: | 34.5 | Buy |
20-day EMA: | 33.81 | Buy |
50-day EMA: | 39.6 | Sell |
200-day EMA: | 64.17 | Sell |
New Concept Energy Earnings Growth & GBR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Vaxcyte Earnings Growth & PCVX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.
New Concept Energy Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vaxcyte Technical Analysis
May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |